Copaxone

Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
Flag link:
Mylan's Copaxone copy could face another hold-up with FDA info request
Mylan's Copaxone copy could face another hold-up with FDA info request
Fierce Pharma
Mylan
Copaxone
FDA
generics
Teva Pharmaceutical
MS
multiple sclerosis
Flag link:
Troubled Teva’s successor to Copaxone just failed a big PhIII test for multiple sclerosis
Troubled Teva’s successor to Copaxone just failed a big PhIII test for multiple sclerosis
Endpoints
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
laquinimod
Active Biotech
Flag link:
Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe
Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe
Yahoo
Teva
Copaxone
Europe
MS
multiple sclerosis
Flag link:
Top 10 U.S. patent losses of 2017
Top 10 U.S. patent losses of 2017
Fierce Pharma
patents
Copaxone
Cialis
Viagra
Velcade
Sustiva
Sandostatin LAR
Norditropin
Viread
Pristiq
Strattera
Pfizer
Teva
Takeda
Eli Lilly
Novartis
Bristol-Myers Squibb
Novo Nordisk
Gilead Sciences
Flag link:
Teva catches break as warning letter looks to delay Momenta Copaxone generic
Teva catches break as warning letter looks to delay Momenta Copaxone generic
Fierce Pharma
Teva Pharmaceutical
Momenta
Copaxone
MS
multiple sclerosis
generics
Flag link:
Top 25 rare disease brands, by sales
Top 25 rare disease brands, by sales
Medical Marketing and Media
rare disease
Copaxone
Teva Pharmaceutical
Avonex
Biogen
Sensipar
Soliris
Alexion
Xyrem
Jazz Pharmaceuticals
Flag link:
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Flag link:
Are Teva Pharmaceutical's Best Days Behind It?
Are Teva Pharmaceutical's Best Days Behind It?
Motley Fool
Teva Pharmaceutical
Copaxone
generics
patents
MS
multiple sclerosis
Flag link:
Teva shares fall as court invalidates patent infringement claims
Teva shares fall as court invalidates patent infringement claims
Marketwatch
Teva Pharmaceutical
patents
Copaxone
Mylan Labs
multiple sclerosis
MS
Flag link:
Third U.S. patent on Teva's MS drug Copaxone invalidated
Third U.S. patent on Teva's MS drug Copaxone invalidated
Reuters
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
patents
Flag link:
Generics creep in as Teva loses two Copaxone patents
Generics creep in as Teva loses two Copaxone patents
BioPharma Dive
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
generics
Glatopa
Novartis
Sandoz
Flag link:
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Motley Fool
Momenta Pharmaceuticals
Teva Pharmaceutical
Copaxone
patents
Mylan Labs
multiple sclerosis
MS
Flag link:
Payers keep squeezing MS drugmakers--and they may just take their tactics elsewhere
Payers keep squeezing MS drugmakers--and they may just take their tactics elsewhere
Fierce Pharma
MS
multiple sclerosis
payers
Sanofi
Aubagio
Teva Pharmaceutical
Copaxone
Biogen
Tecfidera
Avonex
Flag link:
How are Teva and Novartis fending off copycats? By taking discounts straight to payers, analyst says
How are Teva and Novartis fending off copycats? By taking discounts straight to payers, analyst says
Fierce Pharma
Teva Pharmaceutical
Novartis
Gleevec
Copaxone
generics
Flag link:
Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains
Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains
Fierce Pharma
Novartis
Copaxone
MS
multiple sclerosis
biosimilars
Teva
Glatopa
Flag link:
Analysts at Merrill Lynch believe Mylan’s patent challenge will not have a negative impact on Teva
Analysts at Merrill Lynch believe Mylan’s patent challenge will not have a negative impact on Teva
Bidness, ETC
Mylan Labs
Teva Pharmaceutical
patents
generics
Copaxone
MS
multiple sclerosis
Flag link:
U.S. patent office puts new Copaxone's IP shield under the lens
U.S. patent office puts new Copaxone's IP shield under the lens
Fierce Pharma
patents
intellectual property
Copaxone
MS
multiple sclerosis
Flag link:
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Yahoo
Pfizer
Synthon Pharmaceuticals
MS
multiple sclerosis
Copaxone
generics
Flag link:
Teva's MS drug Copaxone has strong second-quarter sales
Teva's MS drug Copaxone has strong second-quarter sales
Yahoo/Reuters
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
earnings
Flag link: